Patents by Inventor Olivier BERTEAU

Olivier BERTEAU has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10981957
    Abstract: The present invention relates to a new class of peptides having antibacterial activity and presenting D-amino acids and their uses. It also relates to a new enzyme presenting a peptide epimerase activity in vitro and in vivo, thereby being useful for modifying peptides in order to change the amino acid configuration from L to D.
    Type: Grant
    Filed: December 1, 2016
    Date of Patent: April 20, 2021
    Assignee: INSTITUT NATIONAL DE RECHERCHE POUR L'AGRICULTURE, L'ALIMENTATION ET L'ENVIRONNEMENT
    Inventors: Alhosna Benjdia, Alain Guillot, Olivier Berteau
  • Patent number: 10214718
    Abstract: Embodiments provide a distributed bioreactor system in which a plurality of modular bioreactors are operated in parallel to produce and maintain a biological cell culture. A central or nurse perfusion bioreactor produces and maintains a cell culture and transfers portions of the cell culture to a plurality of modular peripheral perfusion bioreactors, each of which produces and maintains the cell culture in turn. In order to prevent contamination and facilitate segregation of particular peripheral bioreactors, the distributed system is configured such that one-way fluid communication is established from the central/nurse bioreactor to each of the peripheral bioreactors while maintaining fluid isolation among the peripheral bioreactors. Each modular peripheral bioreactor unit has a plug-and-play configuration and may be plugged into or otherwise coupled to the central/nurse bioreactor to scale up the overall size of the cell culture without requiring sterilization or redesign or reconfiguration of the system.
    Type: Grant
    Filed: July 1, 2014
    Date of Patent: February 26, 2019
    Assignees: University of Massachusetts, APIcells Inc.
    Inventors: Olivier Berteau, Seongkyu Yoon, David Sergeant, Thierry Poskin
  • Publication number: 20180346526
    Abstract: The present invention relates to a new class of peptides having antibacterial activity and presenting D-amino acids and their uses. It also relates to a new enzyme presenting a peptide epimerase activity in vitro and in vivo, thereby being useful for modifying peptides in order to change the amino acid configuration from L to D.
    Type: Application
    Filed: December 1, 2016
    Publication date: December 6, 2018
    Applicant: INSTITUTE NATIONAL DE LA RECHERCHE AGRONOMIQUE (INRA)
    Inventors: ALHOSNA BENJDIA, ALAIN GUILLOT, OLIVIER BERTEAU
  • Publication number: 20160376579
    Abstract: The present invention relates to a new enzyme able to produce 4-hydroxybenzyl alcohol from the amino acid tyrosine and the use thereof for producing 4-hydroxybenzyl alcohol.
    Type: Application
    Filed: December 18, 2014
    Publication date: December 29, 2016
    Inventors: OLIVIER BERTEAU, YVAIN NICOLET, JUAN FONTECILLA-CAMPS, ALHOSNA BENJDIA, ALAIN GUILLOT
  • Publication number: 20160145563
    Abstract: Embodiments provide a distributed bioreactor system in which a plurality of modular bioreactors are operated in parallel to produce and maintain a biological cell culture. A central or nurse perfusion bioreactor produces and maintains a cell culture and transfers portions of the cell culture to a plurality of modular peripheral perfusion bioreactors, each of which produces and maintains the cell culture in turn. In order to prevent contamination and facilitate segregation of particular peripheral bioreactors, the distributed system is configured such that one-way fluid communication is established from the central/nurse bioreactor to each of the peripheral bioreactors while maintaining fluid isolation among the peripheral bioreactors. Each modular peripheral bioreactor unit has a plug-and-play configuration and may be plugged into or otherwise coupled to the central/nurse bioreactor to scale up the over-all size of the cell culture without requiring sterilization or redesign or reconfiguration of the system.
    Type: Application
    Filed: July 1, 2014
    Publication date: May 26, 2016
    Inventors: Olivier BERTEAU, Seongkyu YOON, David SERGEANT, Thierry POSKIN